- Home
- BEPC vs JSPRW Comparison
BEPC vs JSPRW Comparison
Compare BEPC & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEPC
- JSPRW
- Stock Information
- Founded
- BEPC 2019
- JSPRW N/A
- Country
- BEPC United States
- JSPRW United States
- Employees
- BEPC N/A
- JSPRW 45
- Industry
- BEPC Electric Utilities: Central
- JSPRW Biotechnology: Pharmaceutical Preparations
- Sector
- BEPC Utilities
- JSPRW Health Care
- Exchange
- BEPC Nasdaq
- JSPRW Nasdaq
- Market Cap
- BEPC N/A
- JSPRW N/A
- IPO Year
- BEPC N/A
- JSPRW 2020
- Fundamental
- Price
- BEPC $30.27
- JSPRW $0.19
- Analyst Decision
- BEPC Hold
- JSPRW
- Analyst Count
- BEPC 1
- JSPRW 0
- Target Price
- BEPC $32.00
- JSPRW N/A
- AVG Volume (30 Days)
- BEPC 1.1M
- JSPRW N/A
- Earning Date
- BEPC 11-08-2024
- JSPRW N/A
- Dividend Yield
- BEPC 4.68%
- JSPRW N/A
- EPS Growth
- BEPC N/A
- JSPRW N/A
- EPS
- BEPC N/A
- JSPRW N/A
- Revenue
- BEPC $4,754,000,000.00
- JSPRW N/A
- Revenue This Year
- BEPC $27.80
- JSPRW N/A
- Revenue Next Year
- BEPC $6.81
- JSPRW N/A
- P/E Ratio
- BEPC N/A
- JSPRW N/A
- Revenue Growth
- BEPC 18.32
- JSPRW N/A
- 52 Week Low
- BEPC $21.35
- JSPRW N/A
- 52 Week High
- BEPC $35.14
- JSPRW N/A
- Technical
- Relative Strength Index (RSI)
- BEPC 44.80
- JSPRW N/A
- Support Level
- BEPC $29.53
- JSPRW N/A
- Resistance Level
- BEPC $32.06
- JSPRW N/A
- Average True Range (ATR)
- BEPC 1.16
- JSPRW 0.00
- MACD
- BEPC -0.23
- JSPRW 0.00
- Stochastic Oscillator
- BEPC 28.10
- JSPRW 0.00
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.